Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).

NCT01000727 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01000727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01000727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2009
Completion date
April 24, 2014
Enrollment
13,026 (actual)
Sites
914

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome